Multihance and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multihance (gadobenate dimeglumine) and Levaquin (levofloxacin). Common drug interactions include vomiting among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Multihance and Levaquin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

On Jul, 16, 2026

20 people who take Multihance and Levaquin together, and have interactions are studied.

Multihance and Levaquin drug interactions.

What are the common drug interactions of Multihance and Levaquin, by gender? *:

female:

Vomiting
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
General physical health deterioration (weak health status)
Joint stiffness
Pain
Scar
Skin induration (an abnormally hard spot or area on the skin)

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Mobility decreased (ability to move is reduced)
Erythema (redness of the skin)
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Joint stiffness
Pain in extremity
Pruritus (severe itching of the skin)
Skin disorder (skin disease)
Skin fibrosis (fibrous tissue formation on skin)

What are the common drug interactions of Multihance and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pulmonary congestion (congestion in the lungs)
Pulmonary oedema (fluid accumulation in the lungs)
Renal atrophy (wasting of kidney)
Skin discolouration (change of skin colour)
Skin disorder (skin disease)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)

40-49:

Anxiety
Emotional distress
Mobility decreased (ability to move is reduced)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Erythema (redness of the skin)
Gait disturbance
General physical health deterioration (weak health status)
Injury
Joint range of motion decreased (disease of joint movement)

50-59:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Arthralgia (joint pain)
Burning sensation
Deformity (disfigurement)
Erythema (redness of the skin)
Exfoliative rash (scaly red generalized skin rash)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)
Joint stiffness

60+:

Dry skin
Joint range of motion decreased (disease of joint movement)
Skin induration (an abnormally hard spot or area on the skin)
Ascites (accumulation of fluid in the abdominal cavity)
Back pain
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Depression
Fungaemia (fungi circulate in the blood)
Hypersensitivity
Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 9 people, 45.00%
Sleep Apnea Syndrome: 4 people, 20.00%
Brain Stem Syndrome: 4 people, 20.00%
Headache (pain in head): 4 people, 20.00%
High Blood Pressure: 2 people, 10.00%
Pain: 2 people, 10.00%
Nuclear Magnetic Resonance Imaging Abdominal: 2 people, 10.00%
Diabetes: 2 people, 10.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.00%
Venous Pressure Increased: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Multihance and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously